The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Paraquat Neurotoxicity is Distinct from that of MPTP and Rotenone
Abstract
Paraquat, MPTP, and rotenone reproduce features of Parkinson's disease (PD) in experimental animals. The exact mechanisms by which these compounds damage the dopamine system are not firmly established, but selective damage to dopamine neurons and inhibition of complex I are thought to be involved. We and others have previously documented that the toxic metabolite of MPTP, MPP+, is transported into dopamine neurons through the dopamine transporter (DAT), while rotenone is not transported by DAT. We have also demonstrated the requirement for complex I inhibition and oxidative damage in the dopaminergic neurodegeneration produced by rotenone. Based on structural similarity to MPP+, it has been proposed that paraquat exerts selective dopaminergic toxicity through transport by the DAT and subsequent inhibition of mitochondrial complex I. In this study we report that paraquat is neither a substrate nor inhibitor of DAT. We also demonstrate that in vivo exposure to MPTP and rotenone, but not paraquat, inhibits binding of 3H-dihydrorotenone to complex I in brain mitochondria. Rotenone and MPP+ were both effective inhibitors of complex I activity in isolated brain mitochondria, while paraquat exhibited weak inhibitory effects only at millimolar concentrations. These data indicate that, despite the apparent structural similarity to MPP+, paraquat exerts its deleterious effects on dopamine neurons in a manner that is unique from rotenone and MPTP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Self-citationMITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Javitch, J. A., D'Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,263
Nicklas, W. J., Vyas, I., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,262
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,072
Self-citationAbnormalities of the electron transport chain in idiopathic parkinson's disease
Parker, W. D., Boyson, S. J., & Parks, J. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260606 · Cited by 1,063
Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice
Heikkila, R. E., Hess, A., & Duvoisin, R. C. (1984) · Science · doi:10.1126/science.6610213 · Cited by 1,009
Parkinson Disease in Twins: An Etiologic Study
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 867
Ecdysone-inducible gene expression in mammalian cells and transgenic mice.
No, D., Yao, T. P., & Evans, R. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3346 · Cited by 849
McCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J. W., Cory-Slechta, D. A., & Di Monte, D. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0507 · Cited by 838
Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease
Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T., & Kagawa, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91141-8 · Cited by 739
Sherer, T. B., Kim, J.-H., Betarbet, R., & Greenamyre, J. T. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 708
Self-citationEnvironmental risk factors and Parkinson's disease: A case‐control study in Taiwan
Liou, H. H., Tsai, M. C., Chen, C. J., Jeng, J. S., Chang, Y. C., Chen, S. Y., & Chen, R. C. (1997) · Neurology · doi:10.1212/wnl.48.6.1583 · Cited by 616
Jackson-Lewis, V., Jakowec, M., Burke, R. E., & Przedborski, S. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90015-2 · Cited by 609
Parkinson's disease and exposure to agricultural work and pesticide chemicals
Semchuk, K. M., Love, E. J., & Lee, R. G. (1992) · Neurology · doi:10.1212/wnl.42.7.1328 · Cited by 439
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
Brooks, A. I., Chadwick, C. A., Gelbard, H. A., Cory-Slechta, D. A., & Federoff, H. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01192-5 · Cited by 424
Glutathione, iron and Parkinson’s disease
Bharath, S., Hsu, M., Kaur, D., Rajagopalan, S., & Andersen, J. K. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01174-7 · Cited by 396
Dopamine transporters and neuronal injury
Miller, G. W., Gainetdinov, R. R., Levey, A. I., & Caron, M. G. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01379-6 · Cited by 371
Self-citationGainetdinov, R. R., Fumagalli, F., Jones, S. R., & Caron, M. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031322.x · Cited by 353
The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation
Lotharius, J., & O'Malley, K. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005385200 · Cited by 306
Parkinson's disease: A case‐control study of occupational and environmental risk factors
Hertzman, C., Wiens, M., Bowering, D., Snow, B., & Calne, D. (1990) · American Journal of Industrial Medicine · doi:10.1002/ajim.4700170307 · Cited by 290
Role of oxidative stress in paraquat‐induced dopaminergic cell degeneration
McCormack, A. L., Atienza, J. G., Johnston, L. C., Andersen, J. K., Vu, S., & Di Monte, D. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03088.x · Cited by 278
Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes
Chiba, K., Trevor, A. J., & Castagnoli, N. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91071-x · Cited by 269
Carrier-mediated processes in blood–brain barrier penetration and neural uptake of paraquat
Shimizu, K., Ohtaki, K., Matsubara, K., Aoyama, K., Uezono, T., Saito, O., Suno, M., Ogawa, K., Hayase, N., Kimura, K., et al. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02577-x · Cited by 263
Genetic clues to the pathogenesis of Parkinson's disease
Vila, M., & Przedborski, S. (2004) · Nature Medicine · doi:10.1038/nm1068 · Cited by 255
A mechanism of paraquat toxicity in mice and rats
Bus, J. S., Cagen, S. Z., Olgaard, M., & Gibson, J. E. (1976) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(76)90073-9 · Cited by 253
Hoppel, C., DiMarco, J. P., & Tandler, B. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50710-9 · Cited by 234
Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice
Sriram, K., Pai, K. S., Boyd, M. R., & Ravindranath, V. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01271-1 · Cited by 226
Ramsay, R. R., Krueger, M. J., Youngster, S. K., Gluck, M. R., Casida, J. E., & Singer, T. P. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb11409.x · Cited by 209
Immunochemical analysis of dopamine transporter protein in Parkinson's disease
Miller, G. W., Staley, J. K., Heilman, C. J., Perez, J. T., Mash, D. C., Rye, D. B., & Levey, A. I. (1997) · Annals of Neurology · doi:10.1002/ana.410410417 · Cited by 200
Self-citationTillerson, J. L., Caudle, W. M., Reverón, M. E., & Miller, G. W. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8021 · Cited by 191
Self-citationRamsay, R. R., Dadgar, J., Trevor, A., & Singer, T. P. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90037-8 · Cited by 181
Pifl, C., Giros, B., & Caron, M. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04246.1993 · Cited by 175
4‐Hydroxy‐2(E)‐Nonenal Inhibits CNS Mitochondrial Respiration at Multiple Sites
Picklo, M. J., Amarnath, V., McIntyre, J. O., Graham, D. G., & Montine, T. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721617.x · Cited by 163
Schuler, F., & Casida, J. E. (2001) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(01)00183-9 · Cited by 152
Mechanism of cytotoxicity of paraquat
Fukushima, T., Tanaka, K., Lim, H., & Moriyama, M. (2002) · Environmental Health and Preventive Medicine · doi:10.1265/ehpm.2002.89 · Cited by 135
Effects of l ‐dopa and other amino acids against paraquat‐induced nigrostriatal degeneration
McCormack, A. L., & Monte, D. A. D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01621.x · Cited by 131
Uhl, G. R. (1998) · Annals of Neurology · doi:10.1002/ana.410430503 · Cited by 130
Tawara, T., Fukushima, T., Hojo, N., Isobe, A., Shiwaku, K., Setogawa, T., & Yamane, Y. (1996) · Archives of Toxicology · doi:10.1007/s002040050316 · Cited by 112
Pathogenesis of Parkinson's disease.
Sherer, T., Betarbet, R. S., & Greenamyre, J. T. (2001) · PubMed · Cited by 106
Self-citationNakamura, K., Bindokas, V. P., Marks, J. D., Wright, D. A., Frim, D. M., Miller, R. J., & Kang, U. J. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.271 · Cited by 105
Paraquat leads to dopaminergic neural vulnerability in organotypic midbrain culture
Shimizu, K., Matsubara, K., Ohtaki, K., & Shiono, H. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(03)00163-9 · Cited by 94
Higgins, D. S., & Greenamyre, J. T. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-12-03807.1996 · Cited by 92
Self-citationMechanism of cytotoxicity of paraquat
Fukushima, T., Yamada, K., Hojo, N., Isobe, A., Shiwaku, K., & Yamane, Y. (1994) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(11)80056-4 · Cited by 86
Krueger, M. J., Singer, T. P., Casida, J. E., & Ramsay, R. R. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91442-u · Cited by 84
Shang, T., Uihlein, A. V., Asten, J. V., Kalyanaraman, B., & Hillard, C. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01686.x · Cited by 77
Barlow, B. K., Thiruchelvam, M. J., Bennice, L., Cory‐Slechta, D. A., Ballatori, N., & Richfield, E. K. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01773.x · Cited by 73
Quantitative Autoradiography of Dihydrorotenone Binding to Complex I of the Electron Transport Chain
Greenamyre, J. T., Higgins, D. S., & Eller, R. V. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09431.x · Cited by 39
Self-citationStephans, S. E., Miller, G. W., Levey, A. I., & Greenamyre, J. T. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00060-8 · Cited by 30
Self-citationGerlach, M., Götz, M. E., Dirr, A., Kupsch, A. R., Janetzky, B., Oertel, W. H., Sautter, J., Schwarz, J., Reichmann, H., & Riederer, P. F. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00063-e · Cited by 24
Ciliax (1999) · doi:10.1002/(sici)1096-9861(19990621)409:1<38::aid-cne4>3.0.co;2-1
Cited by
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S. R., & Chesselet, M.-F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 913
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell · doi:10.1111/acel.13031 · Cited by 778
Oxidative Stress and Antioxidants in Neurodegenerative Disorders
Olufunmilayo, E. O., Gerke-Duncan, M. B., & Holsinger, R. M. D. (2023) · Antioxidants · doi:10.3390/antiox12020517 · Cited by 670
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Metadata
- Authors
- Richardson, J. R., Quan, Y., Sherer, T. B., Greenamyre, J. T., & Miller, G. W.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-08-24
- Volume
- 88
- Issue
- 1
- Pages
- 193-201
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2114355876
- Cited by
- 275
- References
- 52
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.